Novavax's total assets for Q4 2025 were $1.18B, a decrease of -0.29% from the previous quarter. NVAX total liabilities were $1.30B for the fiscal quarter, a -2.42% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.